drugset / Trial / NCT00129246

Low-Dose Naltrexone Combined With Bupropion to Stop Smoking With Less Weight Gain

NCT00129246

Non-randomizedParallel-groupOpen-labelTreatment

Summary

This study will test a combination of the drugs naltrexone and bupropion with weight-concerned smokers to investigate whether or not this combination of drugs improves smoking cessation quit rates and minimizes post quit weight gain.

Timeline

Start
2004-12
Primary completion
Completion
2005-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Bupropion Small molecule 300 mg
Subject Naltrexone Small molecule 25 mg

Indications